400 related articles for article (PubMed ID: 22062588)
41. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
Matsumoto T; Sasaki N; Yamashita T; Emoto T; Kasahara K; Mizoguchi T; Hayashi T; Yodoi K; Kitano N; Saito T; Yamaguchi T; Hirata K
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1141-51. PubMed ID: 27055906
[TBL] [Abstract][Full Text] [Related]
42. B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells.
Douna H; Amersfoort J; Schaftenaar FH; Kröner MJ; Kiss MG; Slütter B; Depuydt MAC; Bernabé Kleijn MNA; Wezel A; Smeets HJ; Yagita H; Binder CJ; Bot I; van Puijvelde GHM; Kuiper J; Foks AC
Cardiovasc Res; 2020 Feb; 116(2):295-305. PubMed ID: 31150053
[TBL] [Abstract][Full Text] [Related]
43. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.
Meiler S; Smeets E; Winkels H; Shami A; Pascutti MF; Nolte MA; Beckers L; Weber C; Gerdes N; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1748-52. PubMed ID: 27444204
[TBL] [Abstract][Full Text] [Related]
44. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.
Matter CM; Schuler PK; Alessi P; Meier P; Ricci R; Zhang D; Halin C; Castellani P; Zardi L; Hofer CK; Montani M; Neri D; Lüscher TF
Circ Res; 2004 Dec; 95(12):1225-33. PubMed ID: 15539632
[TBL] [Abstract][Full Text] [Related]
45. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
[TBL] [Abstract][Full Text] [Related]
46. Ultrasound Biomicroscopic Imaging for Interleukin-1 Receptor Antagonist-Inhibiting Atherosclerosis and Markers of Inflammation in Atherosclerotic Development in Apolipoprotein-E Knockout Mice.
Li RJ; Sun Y; Wang Q; Yang J; Yang Y; Song L; Wang Z; Luo XH; Su RJ
Tex Heart Inst J; 2015 Aug; 42(4):319-26. PubMed ID: 26413013
[TBL] [Abstract][Full Text] [Related]
47. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
[TBL] [Abstract][Full Text] [Related]
48. Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice.
Pulakazhi Venu VK; Uboldi P; Dhyani A; Patrini A; Baetta R; Ferri N; Corsini A; Muro AF; Catapano AL; Norata GD
Thromb Haemost; 2015 Jul; 114(1):186-97. PubMed ID: 25881051
[TBL] [Abstract][Full Text] [Related]
49. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.
Sharma M; Schlegel MP; Afonso MS; Brown EJ; Rahman K; Weinstock A; Sansbury BE; Corr EM; van Solingen C; Koelwyn GJ; Shanley LC; Beckett L; Peled D; Lafaille JJ; Spite M; Loke P; Fisher EA; Moore KJ
Circ Res; 2020 Jul; 127(3):335-353. PubMed ID: 32336197
[TBL] [Abstract][Full Text] [Related]
50. The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.
Kim CH; Mitchell JB; Bursill CA; Sowers AL; Thetford A; Cook JA; van Reyk DM; Davies MJ
Atherosclerosis; 2015 May; 240(1):234-41. PubMed ID: 25818249
[TBL] [Abstract][Full Text] [Related]
51. Bee Venom Phospholipase A2 Ameliorates Atherosclerosis by Modulating Regulatory T Cells.
Kang GH; Lee S; Choi DB; Shin D; Kim J; Yang H; Bae H
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32977607
[TBL] [Abstract][Full Text] [Related]
52. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
53. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
[TBL] [Abstract][Full Text] [Related]
54. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.
Wei Y; Zhu M; Corbalán-Campos J; Heyll K; Weber C; Schober A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):796-803. PubMed ID: 25810298
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.
Georgiadi A; Wang Y; Stienstra R; Tjeerdema N; Janssen A; Stalenhoef A; van der Vliet JA; de Roos A; Tamsma JT; Smit JW; Tan NS; Müller M; Rensen PC; Kersten S
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1529-37. PubMed ID: 23640487
[TBL] [Abstract][Full Text] [Related]
56. Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability.
Centa M; Jin H; Hofste L; Hellberg S; Busch A; Baumgartner R; Verzaal NJ; Lind Enoksson S; Perisic Matic L; Boddul SV; Atzler D; Li DY; Sun C; Hansson GK; Ketelhuth DFJ; Hedin U; Wermeling F; Lutgens E; Binder CJ; Maegdesfessel L; Malin SG
Circulation; 2019 May; 139(21):2466-2482. PubMed ID: 30894016
[TBL] [Abstract][Full Text] [Related]
57. Regulatory CD4
Kimura T; Kobiyama K; Winkels H; Tse K; Miller J; Vassallo M; Wolf D; Ryden C; Orecchioni M; Dileepan T; Jenkins MK; James EA; Kwok WW; Hanna DB; Kaplan RC; Strickler HD; Durkin HG; Kassaye SG; Karim R; Tien PC; Landay AL; Gange SJ; Sidney J; Sette A; Ley K
Circulation; 2018 Sep; 138(11):1130-1143. PubMed ID: 29588316
[TBL] [Abstract][Full Text] [Related]
58. Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Nasiri-Ansari Ν; Dimitriadis GK; Agrogiannis G; Perrea D; Kostakis ID; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E
Cardiovasc Diabetol; 2018 Jul; 17(1):106. PubMed ID: 30049285
[TBL] [Abstract][Full Text] [Related]
59. Impaired Autophagy in CD11b
Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z
Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723
[TBL] [Abstract][Full Text] [Related]
60. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.
Hu JH; Touch P; Zhang J; Wei H; Liu S; Lund IK; Høyer-Hansen G; Dichek DA
Cardiovasc Res; 2015 Mar; 105(3):372-82. PubMed ID: 25616415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]